107 related articles for article (PubMed ID: 19201190)
21. Design and synthesis of androgen receptor antagonists with bulky side chains for overcoming antiandrogen resistance.
Zhou J; Geng G; Shi Q; Sauriol F; Wu JH
J Med Chem; 2009 Sep; 52(17):5546-50. PubMed ID: 19725582
[TBL] [Abstract][Full Text] [Related]
22. The Sebutape technique for monitoring androgen dependent disorders.
Piérard G; Piérard-Franchimont C
Eur J Med; 1992 May; 1(2):109-12. PubMed ID: 1342365
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and SAR of potent and selective androgen receptor antagonists: 5,6-Dichloro-benzimidazole derivatives.
Ng RA; Guan J; Alford VC; Lanter JC; Allan GF; Sbriscia T; Linton O; Lundeen SG; Sui Z
Bioorg Med Chem Lett; 2007 Feb; 17(3):784-8. PubMed ID: 17095226
[TBL] [Abstract][Full Text] [Related]
24. New progesterone esters as antagonists of androgen receptors.
Cabeza M; Quiroz A; Bratoeff E; Heuze I; Ramírez E; Flores E
Proc West Pharmacol Soc; 2002; 45():166-7. PubMed ID: 12434570
[No Abstract] [Full Text] [Related]
25. Design and synthesis of novel androgen receptor antagonists with sterically bulky icosahedral carboranes.
Goto T; Ohta K; Suzuki T; Ohta S; Endo Y
Bioorg Med Chem; 2005 Dec; 13(23):6414-24. PubMed ID: 16099660
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and SAR of novel hydantoin derivatives as selective androgen receptor modulators.
Zhang X; Allan GF; Sbriscia T; Linton O; Lundeen SG; Sui Z
Bioorg Med Chem Lett; 2006 Nov; 16(22):5763-6. PubMed ID: 16959487
[TBL] [Abstract][Full Text] [Related]
27. Local inhibition of sebaceous gland growth by topically applied RU 58841.
Matias JR; Gaillard M
Ann N Y Acad Sci; 1995 Jun; 761():56-65. PubMed ID: 7625751
[TBL] [Abstract][Full Text] [Related]
28. Novel 17 substituted pregnadiene derivatives as 5 alpha-reductase inhibitors and their binding affinity for the androgen receptor.
Cabeza M; Flores E; Heuze I; Sánchez M; Bratoeff E; Ramírez E; Francolugo VA
Chem Pharm Bull (Tokyo); 2004 May; 52(5):535-9. PubMed ID: 15133203
[TBL] [Abstract][Full Text] [Related]
29. Tandem optimization of target activity and elimination of mutagenic potential in a potent series of N-aryl bicyclic hydantoin-based selective androgen receptor modulators.
Hamann LG; Manfredi MC; Sun C; Krystek SR; Huang Y; Bi Y; Augeri DJ; Wang T; Zou Y; Betebenner DA; Fura A; Seethala R; Golla R; Kuhns JE; Lupisella JA; Darienzo CJ; Custer LL; Price JL; Johnson JM; Biller SA; Zahler R; Ostrowski J
Bioorg Med Chem Lett; 2007 Apr; 17(7):1860-4. PubMed ID: 17292608
[TBL] [Abstract][Full Text] [Related]
30. Discovery of 7alpha-substituted dihydrotestosterones as androgen receptor pure antagonists and their structure-activity relationships.
Tachibana K; Imaoka I; Yoshino H; Emura T; Kodama H; Furuta Y; Kato N; Nakamura M; Ohta M; Taniguchi K; Ishikura N; Nagamuta M; Onuma E; Sato H
Bioorg Med Chem; 2007 Jan; 15(1):174-85. PubMed ID: 17064916
[TBL] [Abstract][Full Text] [Related]
31. Establishment of a novel immortalized human prostatic epithelial cell line stably expressing androgen receptor and its application for the functional screening of androgen receptor modulators.
Yu S; Wang MW; Yao X; Chan FL
Biochem Biophys Res Commun; 2009 May; 382(4):756-61. PubMed ID: 19324023
[TBL] [Abstract][Full Text] [Related]
32. 4-[6-(2-Aminoethyl)naphthalen-2-yl]benzonitriles are potent histamine H3 receptor antagonists with high CNS penetration.
Black LA; Nersesian DL; Sharma P; Ku YY; Bennani YL; Marsh KC; Miller TR; Esbenshade TA; Hancock AA; Cowart M
Bioorg Med Chem Lett; 2007 Mar; 17(5):1443-6. PubMed ID: 17169555
[TBL] [Abstract][Full Text] [Related]
33. Suppression of mutant androgen receptors by flutamide.
Ishioka J; Hara S; Isaacs JT; Tomura A; Nishikawa K; Kageyama Y
Int J Urol; 2009 May; 16(5):516-21. PubMed ID: 19389135
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and structure-activity studies of side-chain derivatized arylhydantoins for investigation as androgen receptor radioligands.
Van Dort ME; Jung YW
Bioorg Med Chem Lett; 2001 Apr; 11(8):1045-7. PubMed ID: 11327585
[TBL] [Abstract][Full Text] [Related]
35. Topical spironolactone reduces sebum secretion rates in young adults.
Yamamoto A; Ito M
J Dermatol; 1996 Apr; 23(4):243-6. PubMed ID: 8935338
[TBL] [Abstract][Full Text] [Related]
36. Screening of 397 chemicals and development of a quantitative structure--activity relationship model for androgen receptor antagonism.
Vinggaard AM; Niemelä J; Wedebye EB; Jensen GE
Chem Res Toxicol; 2008 Apr; 21(4):813-23. PubMed ID: 18324785
[TBL] [Abstract][Full Text] [Related]
37. Is sebosuppression by cimetidine an antiandrogenic effect?
Gloor M; Wirth H; Swoboda U
Acta Derm Venereol; 1981; 61(3):262-4. PubMed ID: 6167114
[TBL] [Abstract][Full Text] [Related]
38. Recent advances in the development of selective androgen receptor modulators.
Zhang X; Lanter JC; Sui Z
Expert Opin Ther Pat; 2009 Sep; 19(9):1239-58. PubMed ID: 19505196
[TBL] [Abstract][Full Text] [Related]
39. Androgen receptors in coeliac ganglion in late pregnant rat.
Vallcaneras SS; Casais M; Delgado SM; Filippa V; Mohamed F; Sosa Z; Rastrilla AM
Steroids; 2009 Jun; 74(6):526-34. PubMed ID: 19428441
[TBL] [Abstract][Full Text] [Related]
40. [Radioprotective agents derived from benzonitrile].
Fernandez JP; Robbe Y; Chapat JP; Cassanas G; Fatome M; Sentenac-Roumanou H
Farmaco Sci; 1986 Jan; 41(1):41-8. PubMed ID: 3956718
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
